Organon Co stock is traded at $13.87, with a volume of 1,075,426. It is down -0.14% in the last 24 hours and up +0.43% over the past month. Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Previous Close:
$13.89
Open:
$13.89
24h Volume:
1,075,426
Relative Volume:
0.37
Market Cap:
$3.64B
Revenue:
$6.16B
Net Income/Loss:
$246.00M
P/E Ratio:
14.78
EPS:
$0.9387
Net Cash Flow:
$708.00M
1W Performance:
+0.29%
1M Performance:
+0.43%
6M Performance:
+4.05%
1Y Performance:
+84.44%
1-Day Range:
$13.86$13.89
1-Week Range:
$13.78$13.89
52-Week Range:
$5.69$13.89
Organon Co Stock (OGN) Company Profile
Name
Organon CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
551-430-6000Address
30 HUDSON STREET, JERSEY CITY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS